Associations between homocysteine, folic acid, vitamin B12 and Alzheimer's disease: Insights from meta-analyses

Journal of Alzheimer's Disease

Volumn 46, Issue 3, 2015, Pages 777-790

  Shen, Liang ^a   Ji, Hong Fang ^a  

^a SHANDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Alzheimer's disease; folic acid; homocysteine; meta analysis; vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; COMPUTER PROGRAM; DATA BASE; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; AGE; BIBLIOGRAPHIC DATABASE; FEMALE; MALE; METABOLISM; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; ALZHEIMER DISEASE; DATABASES, BIBLIOGRAPHIC; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; VITAMIN B 12;

EID: 84934278709     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150140     Document Type: Article

References (89)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3, 186-191.
2. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB (2007) Prevalence of dementia in the United States: The aging, demographics, and memory study. Neuroepidemiology 29, 125-132.
3. Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12, 383-388.
4. Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Benedek GB, Selkoe DJ, Teplow DB (1999) Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem 274, 25945-25952.
5. Sperling RA, Jack CR Jr, Aisen PS (2011) Testing the right target and right drug at the right stage. Sci Transl Med 3, 111.
6. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10, 819-828.
7. Morris MS (2003) Homocysteine and Alzheimer's disease. Lancet Neurol 2, 425-428.
8. Flirski M, Sobow T (2005) Biochemical markers and risk factors of Alzheimer's disease. Curr Alzheimer Res 2, 47-64.
9. Douaud G, Refsum H, de Jager CA, Jacoby R, Nichols TE, Smith SM, Smith AD (2013) Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci USA 110, 9523-9528.
10. Zhuo JM, Wang H, Praticò D (2011) Is hyperhomocysteine-mia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol Sci 32, 562-571.
11. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55, 1449-1455.
12. Leblhuber F, Walli J, Artner-Dworzak E, Vrecko K, Widner B, Reibnegger G, Fuchs D (2000) Hyperhomocysteinemia in dementia. J Neural Transm 107, 1469-1474.
13. Bottiglieri T, Parnetti L, Arning E, Ortiz T, Amici S, Lanari A, Gallai V (2001) Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reduc-tase (MTHFR) gene: A study in an Italian population with dementia. Mech Ageing Dev 122, 2013-2023.
14. Postiglione A, Milan G, Ruocco A, Gallotta G, Guiotto G, Di Minno G (2001) Plasma folate, vitaminB(12), and totalhomo-cysteine and homozygosity for the C677T mutation of the 5, 10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study. Gerontology 47, 324-329.
15. Nilsson K, Gustafson L, Hultberg B (2002) Relation between plasma homocysteine and Alzheimer's disease. Dement Geri-atr Cogn Disord 14, 7-12.
16. Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD (2002) Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neural 59, 787-793.
17. Miller JW, Green R, Mungas DM, Reed BR, Jagust WJ (2002) Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology 58, 1471-1475.
18. Selley ML, Close DR, Stern SE(2002) The effectof increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging 23, 383-388.
19. Mizrahi EH, Jacobsen DW, Debanne SM, Traore F, Lerner AJ, Friedland RP, Petot GJ (2003) Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging. J Nutr Health Aging 7, 160-165.
20. Nagga K, Rajani R, Mardh E, Borch K, Mardh S, Marcusson J (2003) Cobalamin, folate, methylmalonic acid, homocys-teine, and gastritis markers in dementia. Dement Geriatr Cogn Disord 16, 269-275.
21. Religa D, Styczynska M, Peplonska B, Gabryelewicz T, Pfef-fer A, Chodakowska M, Luczywek E, Wasiak B, Stepien K, Golebiowski M, Winblad B, Barcikowska M (2003) Homo-cysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 16, 64-70.
22. Selley ML (2003) Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations ofnitric oxideinthe plasmaofpatients with Alzheimer's disease. Neurobiol Aging 24, 903-907.
23. Gallucci M, Zanardo A, De Valentin L, Vianello A (2004) Homocysteine in Alzheimer disease and vascular dementia. Arch Gerontol Geriatr Suppl 9, 195-200.
24. Genedani S, Rasio G, Cortelli P, Antonelli F, Guidolin D, Galantucci M, Fuxe K, Agnati LF (2004) Studies on homo-cysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer's disease patients and in Parkinson's disease patients. Neurotox Res 6, 327-332.
25. Mizrahi EH, Bowirrat A, Jacobsen DW, Korczyn AD, Traore F, Petot GJ, Lerner AJ, Debanne SM, Adunsky A, Dibello PM, Friedland RP (2004) Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel. J Neurol Sci 227, 109-113.
26. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, Lucca U (2004) Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 80, 114-122.
27. Anello G, Guéant-Rodŕiguez RM, Bosco P, Guéant JL, Romano A, Namour B, Spada R, Caraci F, Pourié G, Daval JL, Ferri R (2004) Homocysteine and methylenetetrahydrofolate reductase polymorphism inAlzheimer's disease. Neuroreport 15, 859-861.
28. Malaguarnera M, Bella R, Alagona G, Ferri R, Carnemolla A, Pennisi G (2004) Helicobacter pylori and Alzheimer's disease: A possible link. Eur J Intern Med 15, 381-386.
29. Dominguez RO, Marschoff ER, Guareschi EM, Famulari AL, Pagano MA, Serra JA (2005) Homocysteine, vitamin B 12 and folate in Alzheimer's and vascular dementias: The paradoxical effect of the superimposed type II diabetes mellitus condition. Clin Chim Acta 359, 163-170.
30. Folin M, Baiguera S, Gallucci M, Conconi MT, Di Liddo R, Zanardo A, Parnigotto PP (2005) A cross-sectional study of homocysteine-, NO-levels, and CT-findings in Alzheimer dementia, vascular dementia and controls. Biogerontology 6, 255-260.
31. Guidi I, Galimberti D, Venturelli E, Lovati C, Del Bo R, Fenoglio C, Gatti A, Dominici R, Galbiati S, Virgilio R, Pomati S, Comi GP, Mariani C, Forloni G, Bresolin N, Scarpini E (2005) Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients. Neurobiol Aging 26, 789-794.
32. Asita De Silva H, Gunatilake SB, Johnston C, Warden D, Smith AD (2005) Medial temporal lobe atrophy, apolipopro-tein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer's disease. Exp Aging Res 31, 345-354.
33. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Tettamanti M, Lucca U (2005) Homocysteine and B vitamins in mild cognitive impairment and dementia. Clin Chem Lab Med 43, 1096-1100.
34. Annerbo S, Wahlund LO, Lokk J (2006) The significance of thyroid-stimulating hormone and homocysteine in the development of Alzheimer's disease in mild cognitive impairment: A 6-year follow-up study. Am J Alzheimers Dis Other Demen 21, 182-188.
35. da Silva VC, Ramos FJ, Fretitas EM, de Brito-Margues PR, Cavalcanti MN, Almeida D, Cabral-Filho V, Muniz JE, MT (2006) Alzheimer's disease in Brazilian elderly has a relation with homocysteine but not with MTHFR polymorphisms.Arq Neuropsiquiatr 64, 941-945.
36. Hernanz A, De la Fuente M, Navarro M, Frank A (2007) Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glyca-tion end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients. Neuroimmunomodulation 14, 163-167.
37. Selley ML (2007) A metabolic link between S adenosyl-homocysteine and polyunsaturatcd fatty acid metabolism in Alzheimer's disease. Neurobiol Aging 28, 1834-1839.
38. Koseoglu E, Karaman Y (2007) Relations between homo-cysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease. Clin Biochem 40, 859-863.
39. Hagnelius NO, Wahlund LO, Nilsson TK (2008) CSF/serum folate gradient: Physiology and determinants with special reference to dementia. Dement Geriatr Cogn Disord 25, 516-523.
40. Lepara O, Alajbegovic A, Zaciragic A, Nakas-Icindic E, Val-jevac A, Lepara D, Hadzovic-Dzuvo A, Fajkic A, Kulo A, Sofic E (2009) Elevated serum homocysteine level is not associated with serum C-reactive protein in patients with probable Alzheimer's disease. J Neural Transm 116, 1651-1656.
41. Villa P, Bosco P, Ferri R, Perri C, Suriano R, Costantini B, Macri F, Proto C, Cento RM, Lanzone A (2009) Fasting and post-methionine homocysteine levels in Alzheimer's disease and vascular dementia. Int Vitam Nutr Res 79, 166-172.
42. Karimi F, Haghighi AB, Petramfar P (2009) Serum levels of homocysteine, vitamin B12, and folic acid in patients with Alzheimer's disease. Iran J Med Sci 34, 181-185.
43. Linnebank M, Popp J, Smulders Y, Smith D, Semm-ler A, Farkas M, Kulic L, Cvetanovska G, Blom H, Stiffel-Wagner B, Kolsch H, Weller M, Jessen F (2010) S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegener Dis 7, 373-378.
44. Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K(2011) Folate and homocysteineinthe cerebrospinalfluid of patients with Alzheimer's disease or dementia: A case control study. Eur Neurol 65, 270-278.
45. Czapski GA, Maruszak A, Styczyńska M, Z? ekanowski C, Safranow K, Strosznajder JB (2012) Association between plasma biomarkers, CDK5 polymorphism and the risk of Alzheimer's disease. Acta Neurobiol Exp (Wars) 72, 397-411.
46. Kim G, Kim H, Kim KN, Son JI, Kim SY, Tamura T, Chang N (2013) Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: A cross-sectional survey. J Alzheimers Dis 33, 853-862.
47. Cervellati C, Romani A, Seripa D, Cremonini E, Bosi C, Magon S, Passaro A, Bergamini CM, Pilotto A, Zuliani G (2013) Oxidative balance, homocysteine, and uric acid levels in older patients with late onset Alzheimer's disease or vascular dementia. J Neurol Sci 337, 156-161.
48. Isobe C, Murata T, Sato C, Terayana Y (2005) Increase oftotal homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease. Life Sci 77, 1836-1843.
49. Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Mintagne P, Nicolas JP (2005) Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: Relation with age and Alzheimer's disease. J Neurol Neurosurg Psychiatry 76, 1585-1587.
50. Popp J, Lewczuk P, Linnebank M, Cveranovska G, Smulders Y, Kolsch H, Frommann I, Kornhuber J, Maier W, Jessen F (2009) Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease. J Alzheimers Dis 18, 819-828.
51. Parnetti L, Mecocci P, Reboldi GP, Santucci C, Brunetti M, Gaiti A, Cadini D, Senin U (1992) Platelet MAO-B activity and vitamin B12inold age dementias.Mol Chem Neuropathol 16, 23-32.
52. Regland B, Abrahamsson L, Blennow K, Gottfries CG, Wallin A (1992) Vitamin B12 in CSF: Reduced CSF/serum B12 ratio in demented men. Acta Neurol Scand 85, 276-281.
53. Joosten E, Lesaffre E, Riezler R, Ghekiere V, Dereymaeker L, Pelemans W, Dejaeger E (1997) Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J Gerontol A Biol Sci Med Sci 52, 76-79.
54. Ravaglia G, Forti P, Maioli F, Vettori C, Grossi G, Bargossi AM, Caldarera M, Franceschi C, Facchini A, Mariani E, Cavalli G (2000) Elevated plasma homocysteine levelsin centenarians are not associated with cognitive impairment. Mech Ageing Dev 121, 251-261.
55. Hogervorst E, Smith AD (2002) The interaction of serum folate and estradiol levels in Alzheimer's disease. Neuro Endocrinol Lett 23, 155-160.
56. Ravaglia G, Forti P, Maioli F, Bianchi G, Martelli M, Talerico T, Servadei L, Zoli M, Mariani E (2004) Plasma amino acid concentrations in patients with amnestic mild cognitive impairment or Alzheimer disease. Am J Clin Nutr 80, 483-488.
57. Irizarry MC, Gurol ME, Raju S, Diaz-Arrastia R, Locascio JJ, Tennis M, Hyman BT, Growdon JH, Greenberg SM, Bot-tiglieri T (2005) Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Neurology 65, 1402-1408.
58. Dominguez RO, Marschoff ER, Guareschi EM, Famulari AL, Pagano MA, Serra JA (2005) Homocysteine, vitamin B 12 and folate in Alzheimer's and vascular dementias: The paradoxical effect of the superimposed type II diabetes mellitus condition. Clin Chim Acta 359, 163-170.
59. Lovati C, Galimberti D, Pomati S, Capiluppi E, Dolci A, Scapellato L, Rosa S, Mailland E, Suardelli M, Vanotti A, Clerici F, Santarato D, Panteghini M, Scarpini E, Mariani C, Bertora P (2007) Serum folate concentrations in patients with cortical and subcortical dementias. Neurosci Lett 420, 213-216.
60. Galimberti G, Conti E, Zini M, Piazza F, Fenaroli F, Isella V, Facheris M, Perlangeli V, Antolini L, DeFilippi F, Ferrarese C (2008) Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? Clin Biochem 41, 914-916.
61. Agarwal R, Chhillar N, Kushwaha S, Singh NK, Tripathi CB (2010) Role of vitamin B (12), folate, and thyroid stimulating hormone in dementia: A hospital-based study in north Indian population. Ann Indian Acad Neurol 13, 257-262.
62. Morillas-Ruiz JM, Rubio-Perez JM, Albaladejo MD, Zafrilla P, Parra S, Vidal-Guevara ML (2010) Effect of an antioxi-dant drink on homocysteine levels in Alzheimer's patients. J Neurol Sci 299, 175-178.
63. Faux NG, Ellis KA, Porter L, Rowler CJ, Laws SM, Martins RN, Pertile KK, Rembach A, Rowe CC, Runble RL, Szoeke C, Taddei K, Taddei T, Trounson BO, Villemagne VL, Ward V, Ames D, Masters CL, Bush AI (2011) Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: Baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle Study. J Alzheimers Dis 27, 909-922.
64. Serot JM, Christmann D, Dubost T, Bene MC, Faure GC (2001) CSF-folate levels are decreased in late-onset AD patients. J Neural Transm 108, 93-99.
65. Kristensen MO, Gulmann NC, Christensen JE, Ostergaard K, Rasmussen K (1993) Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand 87, 475-481.
66. Glaso M, Nordbo G, Diep L, Bohmer T (2004) Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease. J Nutr Health Aging 8, 407-413.
67. Seshadri S, Beiser A, Selhub J, Jacgues PF, Rosenberg IH, Agostino D, Wilson RB, Wolf PW, PA (2002) Plasma homo-cysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346, 476-483.
68. McIIroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP (2002) Moderately elevated plasma homocys-teine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, andAlzheimer diseaseinNorth-ern Ireland. Stroke 33, 2351-2356.
69. Luchsinger JA, Mayeux R (2004) Dietary factors and Alzheimer's disease. Lancet Neurol 3, 579-587.
70. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F (2005) Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 82, 636-643.
71. Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, Mungas DM, Allen LH, Green R (2007) Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: Results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 85, 511-517.
72. Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L (2001) Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology 56, 1188-1194.
73. Maxwell CJ, Hogan DB, Ebly EM (2002) Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons. Dement Geriatr Cogn Disord 13, 225-234.
74. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Pantieri G, Mariani E (2006) Conversion of mild cognitive impairment to dementia: Predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement Geri-atr Cogn Disord 21, 51-58.
75. Farkas M, Keskitalo S, Smith DE, Bain N, Semmler A, Ine-ichen B, Smulders Y, Blom H, Kulic L, Linnebank M (2013) Hyperhomocysteinemia in Alzheimer's disease: The hen and the egg? J Alzheimers Dis 33, 1097-1104.
76. Barnham KJ, Masters CL, Bush AI(2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3, 205-214.
77. Reddy VP, Zhu X, Perry G, Smith MA (2009) Oxidative stress in diabetes and Alzheimer's disease. J Alzheimers Dis 16, 763-774.
78. Chao CL, Kuo TL, Lee YT (2000) Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults. Circulation 101, 485-490.
79. Starkebaum G, Harlan JM (1986) Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 77, 1370-1376.
80. Butterfield DA (2002) Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurode-generation in Alzheimer's disease brain. A review. Free Radic Res 36, 1307-1313.
81. De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282, 11590-11601.
82. Fuchs D, Jaeger M, Widner B, Wirleitner B, Artner-Dworzak E, Leblhuber F (2001) Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake? Clin Chem Lab Med 39, 691-694.
83. Widner B, Fuchs D, Leblhuber F, Sperner-Unterweger B (2001) Does disturbed homocysteine and folate metabolism in depression result from enhanced oxidative stress? J Neurol Neurosurg Psychiatry 70, 419.
84. Hankey GJ, Eikelboom JW (2001) Homocysteine and stroke. Curr Opin Neurol 14, 95-102.
85. Zhang CE, Wei W, Liu YH, Peng JH, Tian Q, Liu GP, Zhang Y, Wang JZ (2009) Hyperhomocysteinemia increases beta amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am J Pathol 174, 1481-1491.
86. Agnati LF, Genedani S, Leo G, Forni A, Woods AS, Filaferro M, Franco R, Fuxe K (2007) Abeta peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer's disease. J Neural Transm 114, 21-31.
87. Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensi-tivity to excitotoxicity. J Neurosci 20, 6920-6926.
88. Sachdev PS (2005) Homocysteine and brain atrophy. Prog Neuropsychopharmacol Biol Psychiatry 29, 1152-1161.
89. Sachdev PS, Valenzuela M, Wang XL, Looi JCL, Brodaty H (2002) Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology 58, 1539-1541.